Journal of Comprehensive Pediatrics

Published by: Kowsar

Liver Involvement in Iranian Children With Cystic Fibrosis: Ultrasonography and Biochemical Findings

Mehri Najafi 1 , Farnaz Najmi Varzaneh 2 , Gholamreza Khatami 1 , Ahmad Khodadad 1 , Gholamhossein Fallahi 1 , Fatemeh Farahmand 1 , Farzaneh Motamed 1 , Mehrzad Mehdizadeh 1 , Houman Alizadeh 1 , Nima Rezaei 1 , 2 , 3 and Maryam Shoaran 1 , *
Authors Information
1 Department of Pediatrics, Children’s Medical Center, Pediatrics Center of Excellence, Tehran University of Medical Sciences, Tehran, IR Iran
2 Research Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, IR Iran
3 Molecular Immunology Research Center; and Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, IR Iran
Article information
  • Journal of Comprehensive Pediatrics: August 10, 2013, 4 (3); 129-33
  • Published Online: June 1, 2013
  • Article Type: Research Article
  • Received: July 18, 2012
  • Revised: February 1, 2013
  • Accepted: February 5, 2013
  • DOI: 10.17795/compreped-7304

To Cite: Najafi M, Najmi Varzaneh F, Khatami G, Khodadad A, Fallahi G, et al. Liver Involvement in Iranian Children With Cystic Fibrosis: Ultrasonography and Biochemical Findings, J Compr Ped. 2013 ; 4(3):129-33. doi: 10.17795/compreped-7304.

Abstract
Copyright © 2013, Iranian Society of Pediatrics. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Feranchak AP. Hepatobiliary complications of cystic fibrosis. Curr Gastroenterol Rep. 2004; 6(3): 231-9[PubMed]
  • 2. Koch C, Cuppens H, Rainisio M, Madessani U, Harms H, Hodson M, et al. European Epidemiologic Registry of Cystic Fibrosis (ERCF): comparison of major disease manifestations between patients with different classes of mutations. Pediatr Pulmonol. 2001; 31(1): 1-12[PubMed]
  • 3. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989; 245(4922): 1066-73[PubMed]
  • 4. Jackson R, Pencharz PB. Transition of care between paediatric and adult gastroenterology. Cystic fibrosis. Best Pract Res Clin Gastroenterol. 2003; 17(2): 213-35[PubMed]
  • 5. Cohn JA, Strong TV, Picciotto MR, Nairn AC, Collins FS, Fitz JG. Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells. Gastroenterology. 1993; 105(6): 1857-64[PubMed]
  • 6. Rowe SM, Miller S, Sorscher EJ. Cystic fibrosis. N Engl J Med. 2005; 352(19): 1992-2001[DOI][PubMed]
  • 7. Lenaerts C, Lapierre C, Patriquin H, Bureau N, Lepage G, Harel F, et al. Surveillance for cystic fibrosis-associated hepatobiliary disease: early ultrasound changes and predisposing factors. J Pediatr. 2003; 143(3): 343-50[DOI][PubMed]
  • 8. Patriquin H, Lenaerts C, Smith L, Perreault G, Grignon A, Filiatrault D, et al. Liver disease in children with cystic fibrosis: US-biochemical comparison in 195 patients. Radiology. 1999; 211(1): 229-32[PubMed]
  • 9. Wilmott RW. Making the diagnosis of cystic fibrosis. J Pediatr. 1998; 132(4): 563-5[PubMed]
  • 10. Patriquin H, Lafortune M, Burns PN, Dauzat M. Duplex Doppler examination in portal hypertension: technique and anatomy. AJR Am J Roentgenol. 1987; 149(1): 71-6[DOI][PubMed]
  • 11. Robinson KA, Middleton WD, Al-Sukaiti R, Teefey SA, Dahiya N. Doppler sonography of portal hypertension. Ultrasound Q. 2009; 25(1): 3-13[DOI][PubMed]
  • 12. Feigelson J, Anagnostopoulos C, Poquet M, Pecau Y, Munck A, Navarro J. Liver cirrhosis in cystic fibrosis--therapeutic implications and long term follow up. Arch Dis Child. 1993; 68(5): 653-7[PubMed]
  • 13. Scott-Jupp R, Lama M, Tanner MS. Prevalence of liver disease in cystic fibrosis. Arch Dis Child. 1991; 66(6): 698-701[PubMed]
  • 14. Campbell PW, 3rd, Phillips JA, 3rd. The cystic fibrosis gene and relationships to clinical status. Semin Respir Infect. 1992; 7(3): 150-7[PubMed]
  • 15. Fallahi G, Najafi M, Farhmand F, Bazvand F, Ahmadi M, Ahmadi F, et al. The clinical and laboratory manifestations of Iranian patients with cystic fibrosis. Turk J Pediatr. 2010; 52(2): 132-8[PubMed]
  • 16. Wilschanski M, Rivlin J, Cohen S, Augarten A, Blau H, Aviram M, et al. Clinical and genetic risk factors for cystic fibrosis-related liver disease. Pediatrics. 1999; 103(1): 52-7[PubMed]
  • 17. Bartlett JR, Friedman KJ, Ling SC, Pace RG, Bell SC, Bourke B, et al. Genetic modifiers of liver disease in cystic fibrosis. JAMA. 2009; 302(10): 1076-83[DOI][PubMed]
  • 18. Corbett K, Kelleher S, Rowland M, Daly L, Drumm B, Canny G, et al. Cystic fibrosis-associated liver disease: a population-based study. J Pediatr. 2004; 145(3): 327-32[DOI][PubMed]
  • 19. Afdhal NH. Biopsy or biomarkers: is there a gold standard for diagnosis of liver fibrosis? Clin Chem. 2004; 50(8): 1299-300[DOI][PubMed]
  • 20. Potter CJ, Fishbein M, Hammond S, McCoy K, Qualman S. Can the histologic changes of cystic fibrosis-associated hepatobiliary disease be predicted by clinical criteria? J Pediatr Gastroenterol Nutr. 1997; 25(1): 32-6[PubMed]
  • 21. Colombo C, Apostolo MG, Ferrari M, Seia M, Genoni S, Giunta A, et al. Analysis of risk factors for the development of liver disease associated with cystic fibrosis. J Pediatr. 1994; 124(3): 393-9[PubMed]
  • 22. Ling SC, Wilkinson JD, Hollman AS, McColl J, Evans TJ, Paton JY. The evolution of liver disease in cystic fibrosis. Arch Dis Child. 1999; 81(2): 129-32[PubMed]
  • 23. Lamireau T, Monnereau S, Martin S, Marcotte JE, Winnock M, Alvarez F. Epidemiology of liver disease in cystic fibrosis: a longitudinal study. J Hepatol. 2004; 41(6): 920-5[DOI][PubMed]
  • 24. Debray D, Kelly D, Houwen R, Strandvik B, Colombo C. Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease. J Cyst Fibros. 2011; 10 Suppl 2-36[DOI][PubMed]
  • 25. Graham N, Manhire AR, Stead RJ, Lees WR, Hodson ME, Batten JC. Cystic fibrosis: ultrasonographic findings in the pancreas and hepatobiliary system correlated with clinical data and pathology. Clin Radiol. 1985; 36(2): 199-203[PubMed]
  • 26. Quillin SP, Siegel MJ, Rothbaum R. Hepatobiliary sonography in cystic fibrosis. Pediatr Radiol. 1993; 23(7): 533-5[PubMed]
  • 27. Williams SG, Westaby D, Tanner MS, Mowat AP. Liver and biliary problems in cystic fibrosis. Br Med Bull. 1992; 48(4): 877-92[PubMed]
  • 28. Lindblad A, Glaumann H, Strandvik B. Natural history of liver disease in cystic fibrosis. Hepatology. 1999; 30(5): 1151-8[DOI][PubMed]
  • 29. Colombo C, Crosignani A, Apostolo MG, Marzano MT, Bettinardi N, Giunta A. Oral bile acids in cystic fibrosis-associated liver disease. J R Soc Med. 1994; 87 Suppl 21: 20-4[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments